Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

YUSIMRY

ADALIMUMAB-AQVH

Standard Dose
40MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview YUSIMRY is listed in Drugs@FDA under application 761216 (BLA).

Marketing status: Prescription Active ingredient ADALIMUMAB-AQVH Form and strength INJECTABLE;INJECTION - 40MG Sponsor COHERUS BIOSCIENCES INC Submission history Latest submission status date: 2025-11-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview YUSIMRY is listed in Drugs@FDA under application 761216 (BLA). Marketing status: Prescription Active ingredient ADALIMUMAB-AQVH Form and strength INJECTABLE;INJECTION - 40MG Sponsor COHERUS BIOSCIENCES INC Submission history Latest submission status date: 2025-11-10 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.